nodes	percent_of_prediction	percent_of_DWPC	metapath
Betamethasone—PLA2G1B—connective tissue—salivary gland cancer	0.0274	0.117	CbGeAlD
Betamethasone—PLA2G1B—epithelium—salivary gland cancer	0.026	0.111	CbGeAlD
Betamethasone—NR3C2—parotid gland—salivary gland cancer	0.0154	0.0658	CbGeAlD
Betamethasone—NR3C2—saliva-secreting gland—salivary gland cancer	0.0148	0.063	CbGeAlD
Betamethasone—NR3C2—connective tissue—salivary gland cancer	0.0136	0.0579	CbGeAlD
Betamethasone—PGR—connective tissue—salivary gland cancer	0.0126	0.0538	CbGeAlD
Betamethasone—PGR—epithelium—salivary gland cancer	0.012	0.0511	CbGeAlD
Betamethasone—CYP19A1—connective tissue—salivary gland cancer	0.0114	0.0485	CbGeAlD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—KRT14—salivary gland cancer	0.0108	0.0141	CbGpPWpGaD
Betamethasone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAP2K2—salivary gland cancer	0.0103	0.0134	CbGpPWpGaD
Betamethasone—NR3C1—neck—salivary gland cancer	0.0102	0.0433	CbGeAlD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—EN1—salivary gland cancer	0.01	0.0131	CbGpPWpGaD
Betamethasone—PGR—Ovarian Infertility Genes—ATM—salivary gland cancer	0.01	0.0131	CbGpPWpGaD
Betamethasone—PGR—Generic Transcription Pathway—ZIM2—salivary gland cancer	0.00967	0.0126	CbGpPWpGaD
Betamethasone—PGR—lymphoid tissue—salivary gland cancer	0.00923	0.0394	CbGeAlD
Betamethasone—NR3C2—Preimplantation Embryo—CDH1—salivary gland cancer	0.00881	0.0115	CbGpPWpGaD
Betamethasone—PGR—Validated nuclear estrogen receptor alpha network—BRCA1—salivary gland cancer	0.00853	0.0111	CbGpPWpGaD
Betamethasone—NR3C1—parotid gland—salivary gland cancer	0.00828	0.0353	CbGeAlD
Betamethasone—NR3C1—saliva-secreting gland—salivary gland cancer	0.00793	0.0338	CbGeAlD
Betamethasone—NR3C1—Adipogenesis—WNT5B—salivary gland cancer	0.00774	0.0101	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—ZIM2—salivary gland cancer	0.00764	0.00999	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—MYB—salivary gland cancer	0.0073	0.00953	CbGpPWpGaD
Betamethasone—NR3C1—connective tissue—salivary gland cancer	0.00729	0.0311	CbGeAlD
Betamethasone—NR3C2—Generic Transcription Pathway—MAML3—salivary gland cancer	0.00709	0.00926	CbGpPWpGaD
Betamethasone—NR3C1—epithelium—salivary gland cancer	0.00692	0.0295	CbGeAlD
Betamethasone—PTGS2—C-MYB transcription factor network—SMARCA2—salivary gland cancer	0.00683	0.00893	CbGpPWpGaD
Betamethasone—PGR—Signaling by ERBB4—FGF16—salivary gland cancer	0.00673	0.00879	CbGpPWpGaD
Betamethasone—CYP19A1—Ovarian Infertility Genes—ATM—salivary gland cancer	0.00656	0.00857	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—UHRF1—salivary gland cancer	0.0065	0.00849	CbGpPWpGaD
Betamethasone—PTGS2—connective tissue—salivary gland cancer	0.00631	0.0269	CbGeAlD
Betamethasone—PTGS2—epithelium—salivary gland cancer	0.00599	0.0255	CbGeAlD
Betamethasone—ABCB1—Constitutive Androstane Receptor Pathway—SMC1A—salivary gland cancer	0.00583	0.00762	CbGpPWpGaD
Betamethasone—NR3C2—lymph node—salivary gland cancer	0.0056	0.0239	CbGeAlD
Betamethasone—NR3C1—Generic Transcription Pathway—ZIM2—salivary gland cancer	0.00559	0.0073	CbGpPWpGaD
Betamethasone—NR3C1—lymphoid tissue—salivary gland cancer	0.00533	0.0227	CbGeAlD
Betamethasone—PGR—lymph node—salivary gland cancer	0.00521	0.0222	CbGeAlD
Betamethasone—PGR—Signaling by ERBB4—FGFR4—salivary gland cancer	0.00497	0.00649	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—ARID4B—salivary gland cancer	0.00493	0.00644	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—NFIB—salivary gland cancer	0.00493	0.00644	CbGpPWpGaD
Betamethasone—PTGS2—C-MYB transcription factor network—MYB—salivary gland cancer	0.00478	0.00624	CbGpPWpGaD
Betamethasone—PLA2G1B—Fc-epsilon receptor I signaling in mast cells—PIK3CA—salivary gland cancer	0.0047	0.00613	CbGpPWpGaD
Betamethasone—CYP19A1—lymph node—salivary gland cancer	0.00469	0.02	CbGeAlD
Betamethasone—PGR—Gene Expression—ZIM2—salivary gland cancer	0.00466	0.00608	CbGpPWpGaD
Betamethasone—PTGS2—lymphoid tissue—salivary gland cancer	0.00461	0.0197	CbGeAlD
Betamethasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CREBBP—salivary gland cancer	0.00448	0.00585	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—AQP1—salivary gland cancer	0.00436	0.0057	CbGpPWpGaD
Betamethasone—PLA2G1B—Fc-epsilon receptor I signaling in mast cells—HRAS—salivary gland cancer	0.00434	0.00567	CbGpPWpGaD
Betamethasone—PGR—Generic Transcription Pathway—MAML3—salivary gland cancer	0.00432	0.00564	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—ISYNA1—salivary gland cancer	0.00419	0.00547	CbGpPWpGaD
Betamethasone—PGR—Signaling by ERBB4—FOXO3—salivary gland cancer	0.00412	0.00539	CbGpPWpGaD
Betamethasone—NR3C2—Generic Transcription Pathway—MAML2—salivary gland cancer	0.00397	0.00519	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—UHRF1—salivary gland cancer	0.00396	0.00517	CbGpPWpGaD
Betamethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOXO3—salivary gland cancer	0.00394	0.00515	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—MYB—salivary gland cancer	0.00384	0.00502	CbGpPWpGaD
Betamethasone—ABCB1—epithelium—salivary gland cancer	0.0037	0.0158	CbGeAlD
Betamethasone—PGR—Validated nuclear estrogen receptor alpha network—CCND1—salivary gland cancer	0.0037	0.00483	CbGpPWpGaD
Betamethasone—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—salivary gland cancer	0.00359	0.00469	CbGpPWpGaD
Betamethasone—PLA2G1B—Phospholipid metabolism—PTEN—salivary gland cancer	0.00346	0.00452	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—VCAN—salivary gland cancer	0.00343	0.00448	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—MAML3—salivary gland cancer	0.00341	0.00446	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—MARCKS—salivary gland cancer	0.00341	0.00446	CbGpPWpGaD
Betamethasone—PGR—Validated nuclear estrogen receptor alpha network—EP300—salivary gland cancer	0.0034	0.00444	CbGpPWpGaD
Betamethasone—PGR—Signaling by ERBB4—MAP2K2—salivary gland cancer	0.00337	0.0044	CbGpPWpGaD
Betamethasone—NR3C1—Regulation of Androgen receptor activity—CREBBP—salivary gland cancer	0.00336	0.00439	CbGpPWpGaD
Betamethasone—NR3C1—Circadian Clock—CREBBP—salivary gland cancer	0.00326	0.00426	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—PYGB—salivary gland cancer	0.00317	0.00415	CbGpPWpGaD
Betamethasone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FOXO3—salivary gland cancer	0.00317	0.00414	CbGpPWpGaD
Betamethasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—salivary gland cancer	0.00305	0.00398	CbGpPWpGaD
Betamethasone—NR3C1—Endoderm Differentiation—NOTCH1—salivary gland cancer	0.00303	0.00396	CbGpPWpGaD
Betamethasone—NR3C1—lymph node—salivary gland cancer	0.00301	0.0128	CbGeAlD
Betamethasone—PGR—Gene Expression—NFIB—salivary gland cancer	0.003	0.00392	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—ARID4B—salivary gland cancer	0.003	0.00392	CbGpPWpGaD
Betamethasone—ABCB1—lymphoid tissue—salivary gland cancer	0.00285	0.0122	CbGeAlD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—BRCA1—salivary gland cancer	0.00282	0.00368	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—ZIM2—salivary gland cancer	0.00269	0.00352	CbGpPWpGaD
Betamethasone—PTGS2—lymph node—salivary gland cancer	0.0026	0.0111	CbGeAlD
Betamethasone—PLA2G1B—Metabolism—PHGDH—salivary gland cancer	0.00259	0.00338	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—MAML3—salivary gland cancer	0.0025	0.00326	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—ST3GAL4—salivary gland cancer	0.00249	0.00325	CbGpPWpGaD
Betamethasone—PLA2G1B—Phospholipid metabolism—PIK3CA—salivary gland cancer	0.00244	0.00319	CbGpPWpGaD
Betamethasone—PGR—Generic Transcription Pathway—MAML2—salivary gland cancer	0.00242	0.00316	CbGpPWpGaD
Betamethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREBBP—salivary gland cancer	0.00239	0.00312	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—CREBBP—salivary gland cancer	0.00237	0.00309	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—ERBB2IP—salivary gland cancer	0.00229	0.003	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—UHRF1—salivary gland cancer	0.00229	0.00299	CbGpPWpGaD
Betamethasone—NR3C1—Regulation of Androgen receptor activity—EP300—salivary gland cancer	0.00229	0.00299	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—AQP1—salivary gland cancer	0.00226	0.00295	CbGpPWpGaD
Betamethasone—NR3C1—Circadian Clock—EP300—salivary gland cancer	0.00222	0.0029	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—FOXO3—salivary gland cancer	0.00221	0.00289	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—NUP62—salivary gland cancer	0.00211	0.00276	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—MAML3—salivary gland cancer	0.00208	0.00272	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—CCND1—salivary gland cancer	0.00199	0.0026	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TOP2A—salivary gland cancer	0.00195	0.00255	CbGpPWpGaD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—EP300—salivary gland cancer	0.00194	0.00254	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—PTEN—salivary gland cancer	0.00192	0.00251	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—MAML2—salivary gland cancer	0.00191	0.0025	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—ATM—salivary gland cancer	0.0019	0.00248	CbGpPWpGaD
Betamethasone—NR3C2—Generic Transcription Pathway—NOTCH1—salivary gland cancer	0.00187	0.00245	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—EP300—salivary gland cancer	0.00183	0.00239	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	0.00182	0.00238	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—NUP62—salivary gland cancer	0.00179	0.00234	CbGpPWpGaD
Betamethasone—PGR—Signaling by ERBB4—PTEN—salivary gland cancer	0.00179	0.00233	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—VCAN—salivary gland cancer	0.00178	0.00232	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—SMC1A—salivary gland cancer	0.00177	0.00231	CbGpPWpGaD
Betamethasone—PTGS2—C-MYB transcription factor network—CREBBP—salivary gland cancer	0.00176	0.0023	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—ARID4B—salivary gland cancer	0.00173	0.00227	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—NFIB—salivary gland cancer	0.00173	0.00227	CbGpPWpGaD
Betamethasone—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—salivary gland cancer	0.00173	0.00226	CbGpPWpGaD
Betamethasone—NR3C2—Generic Transcription Pathway—CREBBP—salivary gland cancer	0.0017	0.00222	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—CDH1—salivary gland cancer	0.00164	0.00214	CbGpPWpGaD
Betamethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—salivary gland cancer	0.00163	0.00213	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—EP300—salivary gland cancer	0.00161	0.00211	CbGpPWpGaD
Betamethasone—ABCB1—lymph node—salivary gland cancer	0.00161	0.00686	CbGeAlD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.00156	0.00204	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA1—salivary gland cancer	0.00156	0.00204	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—WNT5B—salivary gland cancer	0.00153	0.002	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—ISYNA1—salivary gland cancer	0.00153	0.002	CbGpPWpGaD
Betamethasone—ABCB1—HIF-1-alpha transcription factor network—CREBBP—salivary gland cancer	0.00151	0.00198	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IL17RD—salivary gland cancer	0.00148	0.00193	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—CREBBP—salivary gland cancer	0.00142	0.00185	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—MAML2—salivary gland cancer	0.0014	0.00183	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—salivary gland cancer	0.00138	0.00181	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MAML3—salivary gland cancer	0.00135	0.00177	CbGpPWpGaD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—HRAS—salivary gland cancer	0.00133	0.00174	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—TP53—salivary gland cancer	0.00131	0.00171	CbGpPWpGaD
Betamethasone—PTGS2—C-MYB transcription factor network—CCND1—salivary gland cancer	0.0013	0.0017	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—NUP62—salivary gland cancer	0.00128	0.00168	CbGpPWpGaD
Betamethasone—PGR—Signaling by ERBB4—PIK3CA—salivary gland cancer	0.00126	0.00165	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—MARCKS—salivary gland cancer	0.00125	0.00163	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—CCND1—salivary gland cancer	0.00122	0.00159	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MC3R—salivary gland cancer	0.00121	0.00157	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—MAML3—salivary gland cancer	0.0012	0.00157	CbGpPWpGaD
Betamethasone—PTGS2—C-MYB transcription factor network—EP300—salivary gland cancer	0.0012	0.00157	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—PTEN—salivary gland cancer	0.00118	0.00154	CbGpPWpGaD
Betamethasone—PGR—Signaling by ERBB4—HRAS—salivary gland cancer	0.00117	0.00152	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—MAML2—salivary gland cancer	0.00116	0.00152	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—ST3GAL4—salivary gland cancer	0.00116	0.00152	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PYGB—salivary gland cancer	0.00116	0.00151	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—TP53—salivary gland cancer	0.00115	0.00151	CbGpPWpGaD
Betamethasone—PGR—Generic Transcription Pathway—NOTCH1—salivary gland cancer	0.00114	0.00149	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—EP300—salivary gland cancer	0.00112	0.00147	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.00112	0.00146	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA1—salivary gland cancer	0.00111	0.00144	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—SMC1A—salivary gland cancer	0.00108	0.0014	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.00106	0.00139	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—DTX4—salivary gland cancer	0.00105	0.00138	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—ATM—salivary gland cancer	0.00105	0.00137	CbGpPWpGaD
Betamethasone—PGR—Generic Transcription Pathway—CREBBP—salivary gland cancer	0.00103	0.00135	CbGpPWpGaD
Betamethasone—ABCB1—HIF-1-alpha transcription factor network—EP300—salivary gland cancer	0.00103	0.00135	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—ISYNA1—salivary gland cancer	0.00102	0.00134	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—CCND1—salivary gland cancer	0.000993	0.0013	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—EP300—salivary gland cancer	0.000964	0.00126	CbGpPWpGaD
Betamethasone—PTGS2—Disease—WNT5B—salivary gland cancer	0.000958	0.00125	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PHGDH—salivary gland cancer	0.000945	0.00123	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CPSF4—salivary gland cancer	0.000925	0.00121	CbGpPWpGaD
Betamethasone—PTGS2—Disease—IL17RD—salivary gland cancer	0.000925	0.00121	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PYGB—salivary gland cancer	0.000925	0.00121	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—CREBBP—salivary gland cancer	0.000913	0.00119	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—ST3GAL4—salivary gland cancer	0.00091	0.00119	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—NOTCH1—salivary gland cancer	0.000902	0.00118	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—FGF16—salivary gland cancer	0.000871	0.00114	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MAML3—salivary gland cancer	0.000846	0.0011	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.000835	0.00109	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—MARCKS—salivary gland cancer	0.000833	0.00109	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—AQP1—salivary gland cancer	0.000826	0.00108	CbGpPWpGaD
Betamethasone—PTGS2—C-MYB transcription factor network—HRAS—salivary gland cancer	0.000821	0.00107	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—CREBBP—salivary gland cancer	0.000818	0.00107	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—TP53—salivary gland cancer	0.000803	0.00105	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	0.000787	0.00103	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PYGB—salivary gland cancer	0.000775	0.00101	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MAML2—salivary gland cancer	0.000757	0.000989	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—salivary gland cancer	0.000744	0.000972	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—NUP62—salivary gland cancer	0.000743	0.00097	CbGpPWpGaD
Betamethasone—PTGS2—Disease—ST3GAL4—salivary gland cancer	0.000726	0.000948	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ISYNA1—salivary gland cancer	0.000724	0.000946	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—CREBBP—salivary gland cancer	0.000695	0.000909	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—salivary gland cancer	0.000675	0.000882	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—MAML2—salivary gland cancer	0.000673	0.000879	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.000662	0.000865	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—NOTCH1—salivary gland cancer	0.00066	0.000862	CbGpPWpGaD
Betamethasone—PTGS2—Disease—DTX4—salivary gland cancer	0.000659	0.000861	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—NUP62—salivary gland cancer	0.000655	0.000856	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—TP53—salivary gland cancer	0.000654	0.000854	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—salivary gland cancer	0.000652	0.000851	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—VCAN—salivary gland cancer	0.00065	0.000849	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—salivary gland cancer	0.000647	0.000845	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—JAG1—salivary gland cancer	0.000646	0.000844	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—FGFR4—salivary gland cancer	0.000644	0.000841	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—FBXW7—salivary gland cancer	0.000633	0.000827	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PHGDH—salivary gland cancer	0.000631	0.000825	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—SMC1A—salivary gland cancer	0.000622	0.000812	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—salivary gland cancer	0.000621	0.000812	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—ST3GAL4—salivary gland cancer	0.000608	0.000794	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—CREBBP—salivary gland cancer	0.000598	0.000781	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—MARCKS—salivary gland cancer	0.000591	0.000771	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.00057	0.000745	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—AQP1—salivary gland cancer	0.000552	0.000721	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—NOTCH1—salivary gland cancer	0.000549	0.000718	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PYGB—salivary gland cancer	0.000549	0.000717	CbGpPWpGaD
Betamethasone—PTGS2—Disease—FGF16—salivary gland cancer	0.000545	0.000712	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—FOXO3—salivary gland cancer	0.000534	0.000698	CbGpPWpGaD
Betamethasone—PTGS2—Disease—NUP62—salivary gland cancer	0.000523	0.000683	CbGpPWpGaD
Betamethasone—PTGS2—Disease—VCAN—salivary gland cancer	0.000518	0.000677	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—CREBBP—salivary gland cancer	0.000498	0.000651	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—PTEN—salivary gland cancer	0.000497	0.000649	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—salivary gland cancer	0.000479	0.000625	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—EP300—salivary gland cancer	0.000474	0.000619	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MAML2—salivary gland cancer	0.000473	0.000618	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—salivary gland cancer	0.000462	0.000603	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	0.00046	0.000601	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PHGDH—salivary gland cancer	0.000448	0.000585	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ISYNA1—salivary gland cancer	0.000446	0.000583	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	0.000445	0.000581	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—salivary gland cancer	0.000441	0.000576	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—NUP62—salivary gland cancer	0.000438	0.000572	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MAP2K2—salivary gland cancer	0.000436	0.00057	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—VCAN—salivary gland cancer	0.000434	0.000567	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ST3GAL4—salivary gland cancer	0.000431	0.000563	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000407	0.000532	CbGpPWpGaD
Betamethasone—PTGS2—Disease—JAG1—salivary gland cancer	0.000404	0.000528	CbGpPWpGaD
Betamethasone—PTGS2—Disease—FGFR4—salivary gland cancer	0.000403	0.000526	CbGpPWpGaD
Betamethasone—PTGS2—Disease—FBXW7—salivary gland cancer	0.000396	0.000517	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—AQP1—salivary gland cancer	0.000391	0.000511	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.000388	0.000507	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000381	0.000498	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—MARCKS—salivary gland cancer	0.000364	0.000475	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—NOTCH1—salivary gland cancer	0.000357	0.000467	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—PIK3CA—salivary gland cancer	0.00035	0.000458	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PYGB—salivary gland cancer	0.000338	0.000442	CbGpPWpGaD
Betamethasone—PTGS2—Disease—FOXO3—salivary gland cancer	0.000334	0.000436	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	0.000326	0.000426	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CREBBP—salivary gland cancer	0.000324	0.000423	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—NOTCH1—salivary gland cancer	0.000318	0.000415	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	0.000315	0.000412	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—NUP62—salivary gland cancer	0.00031	0.000405	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—VCAN—salivary gland cancer	0.000308	0.000402	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—CREBBP—salivary gland cancer	0.000288	0.000376	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	0.000287	0.000375	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PHGDH—salivary gland cancer	0.000276	0.00036	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MAP2K2—salivary gland cancer	0.000273	0.000356	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000272	0.000355	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ST3GAL4—salivary gland cancer	0.000265	0.000347	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.00026	0.000339	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000257	0.000336	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—CREBBP—salivary gland cancer	0.000254	0.000332	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—AQP1—salivary gland cancer	0.000241	0.000315	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CCND1—salivary gland cancer	0.00024	0.000313	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PTEN—salivary gland cancer	0.000231	0.000302	CbGpPWpGaD
Betamethasone—PTGS2—Disease—NOTCH1—salivary gland cancer	0.000223	0.000292	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—EP300—salivary gland cancer	0.000221	0.000288	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CREBBP—salivary gland cancer	0.000203	0.000265	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	0.000192	0.000251	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—NUP62—salivary gland cancer	0.000191	0.00025	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—VCAN—salivary gland cancer	0.00019	0.000248	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PTEN—salivary gland cancer	0.000181	0.000237	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—EP300—salivary gland cancer	0.000173	0.000226	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CREBBP—salivary gland cancer	0.00017	0.000222	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PIK3CA—salivary gland cancer	0.000163	0.000213	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TP53—salivary gland cancer	0.000158	0.000206	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—HRAS—salivary gland cancer	0.000151	0.000197	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PTEN—salivary gland cancer	0.000145	0.000189	CbGpPWpGaD
Betamethasone—PTGS2—Disease—EP300—salivary gland cancer	0.000138	0.00018	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PIK3CA—salivary gland cancer	0.000128	0.000167	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PTEN—salivary gland cancer	0.000121	0.000158	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CREBBP—salivary gland cancer	0.00012	0.000157	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—EP300—salivary gland cancer	0.000116	0.000151	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PIK3CA—salivary gland cancer	0.000102	0.000133	CbGpPWpGaD
Betamethasone—PTGS2—Disease—HRAS—salivary gland cancer	9.45e-05	0.000123	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PTEN—salivary gland cancer	8.59e-05	0.000112	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PIK3CA—salivary gland cancer	8.55e-05	0.000112	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—EP300—salivary gland cancer	8.19e-05	0.000107	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CREBBP—salivary gland cancer	7.41e-05	9.68e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PIK3CA—salivary gland cancer	6.06e-05	7.92e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PTEN—salivary gland cancer	5.29e-05	6.91e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—EP300—salivary gland cancer	5.05e-05	6.59e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PIK3CA—salivary gland cancer	3.73e-05	4.88e-05	CbGpPWpGaD
